Biotechnology and Biodefense Enterprise: An Industry Perspective on Defence Acquisition-Reference-Cited by-同舟云学术

Biotechnology and Biodefense Enterprise: An Industry Perspective on Defence Acquisition

Published:2022-07-27 Issue:1 Volume:7 Page:37-43
ISSN:2377-9497
Container-title:Global Security: Health, Science and Policy
language:en
Short-container-title:Global Security: Health, Science and Policy

Author:

Yeh Kenneth B.¹,Du Eric²,Olinger Gene¹,Boston Donna³

Affiliation:

1. Life Sciences Division, MRIGlobal, Gaithersburg, MD, USA

2. Healthcare & Life Sciences Strategy Group, KPMG LLP US, Foster City, San Francisco, USA

3. DSBio Consulting, Annapolis, MD, USA

Publisher

Informa UK Limited

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/23779497.2022.2102527

Reference19 articles.

1. Ardizzone, K. & Love, J. (2020). Other transaction agreements: Government contracts that eliminate protections for the public on pricing, access and competition, including in connection with COVID-19 vaccines and treatments. https://www.keionline.org/wp-content/uploads/KEI-Briefing-OTA-29june2020.pdf

2. Breaching the Department of Defense's Biotech Bottleneck

3. Pharma Success in Product Development—Does Biotechnology Change the Paradigm in Product Development and Attrition

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Military Medicine and Medical Research as a Source of Inspiration and Innovation to Solve National Security and Health Challenges in the 21st Century;Pathogens and Immunity;2023-09-08

2. Retrospective on molecular assay design for detecting pan-orthopox viruses and prospective on mpox laboratory preparedness and readiness;Frontiers in Tropical Diseases;2023-07-26